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Abstract:  
Squalene is the main unsaponifiable component of virgin olive oil, the main source of 
dietary fat in Mediterranean diet, traditionally associated with a less frequency of 
cardiovascular diseases. In this study, two experimental approaches were used. The 
first, New Zealand rabbits fed for 4 weeks with a chow diet enriched in 1% sunflower 
oil for the control group, and in 1% of sunflower oil and 0.5% squalene for the 
squalene group.  In the second, APOE KO mice received either Western diet or 
Western diet enriched in 0.5% squalene for 11 weeks. In both studies, liver samples 
were obtained and analyzed for their squalene content by gas chromatography-mass 
spectrometry. Hepatic distribution of squalene was also characterized in isolated 
subcellular organelles. Our results show that dietary squalene accumulates in the liver 
and a differential distribution according to studied model. In this regard, rabbits 
accumulated in cytoplasm within small size vesicles,  whose size was not big enough to 
be considered lipid droplets, rough endoplasmic reticulum  and nuclear and plasma 
membrane. On the contrary, mice accumulated in large lipid droplets, and smooth 
reticulum fractions in addition to nuclear and plasma membrane. These results show 
that the squalene cellular localization may change according to experimental setting 
and be a starting point to characterize the mechanisms involved in the protective 
action of dietary squalene in several pathologies. 
 
Keywords: Squalene, the liver, subcellular fractions, steatosis 
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Introduction. 
Non-alcoholic fatty liver disease (NAFLD) is now viewed as a considerable health issue 
since it affects about 25% of the USA population, and up to 30% of these patients will 
develop more severe diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, 
and in some cases hepatocellular carcinoma [14]. The liver, as an organ with a major 
role in metabolizing glucose, fatty acids, and cholesterol, seems particularly sensitive 
to the increased incidence of human obesity in the modern society, and is becoming a 
lipid-accumulating tissue as well, and as consequence, promoting insulin resistance in 
human peripheral tissues [12]. NAFLD does not show symptoms so, when detected in a 
regular analytical, it is complicated to reverse the damage for the advanced stages of 
the disease, it is crucial to identify the first symptoms, and to provide early effective 
treatment for this ailment [4].  
Squalene is an isoprenoid lipid belonging to the terpene family with linear structure 
and six double bounds, firstly isolated from shark livers where it accumulates with no 
apparent damage to the organ [21]. In addition, it is also present in amaranth and 
virgin olive oils [21]. Squalene is the precursor of sterol biosynthesis in all cell types 
and is located in the midplane of the lipid bilayer [9]. Moreover, It has been proposed 
that squalene could be a bioactive compound [17] able to act as antioxidant [30,19,5], 
anti-inflammatory  [6,7,23] or as antineoplastic agent against skin, colon, and lung 
cancer cells as well as sarcoma [22,16,18,24]. Not surprisingly, some authors have 
considered it as an effective therapeutic agent in treatment of age-associated 
disorders where free radicals are a major causative factor [1].  
Using APOE-KO mice as model of spontaneous atherosclerosis and fatty liver [3], the 
administration of dietary squalene decreased atherosclerotic lesion, and in males, this 
lesion correlated with hepatic fat content, what suggested that squalene 
administration could be used as a safe alternative to correct hepatic steatosis and 
atherosclerosis, particularly in males [8]. Using high-throughput approaches, it was 
found that the normalization of the steatotic liver by squalene was associated with 
complex mechanisms involving mitochondria and endoplasmic reticulum [19,20]. 
Recently, it has been shown in HepG2 cells that squalene behaves as a peroxisome 
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proliferator-activated receptor-α agonist, decreasing cellular triacylglycerol and 
cholesterol concentrations, while fatty acid uptake was increased [10]. These facts 
together with that the liver is the main squalene body storage [28,9], make this 
compound an attractive agent in the field of NAFLD. In adipose tissue, two pools of 
squalene were shown to exist, one in lipid droplets and other in microsomes [27].  To 
our knowledge, no study has addressed the subcellular distribution of squalene in the 
liver and mechanisms controlling those pools. The present endeavor has set up to 
characterize the subcellular distribution of squalene in two animal models. 
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Material and methods. 
Animals and diets. 
During 4 weeks, two groups of 6 male New Zealand rabbits were fed with a chow diet 
enriched with 1% of sunflower oil for the control group, and with 1% of sunflower oil 
and 0.5% of squalene for the squalene group. After this period, the rabbits were fasted 
for 18 hours and liver was obtained for assays. The samples were stored at -80 ºC. 
The mice experiment used two groups of 17 male APOE-KO, which were fed a purified 
Western diet for the control group and a purified Western diet supplemented with 
0.5% of squalene for the squalene group. After the 10-week diet intervention, and 
four-hour fast, the animals were killed by suffocation with CO2. The livers were 
removed, weighed, frozen in liquid nitrogen, and stored at − 80 °C until analysis. 
Animals were handled and killed observing guidelines (Directive 2010/63/UE) from the 
European Union for care and use of laboratory animals in research, and the protocols 
were approved by the Ethics Committee for Animal Research of the University of 
Zaragoza. 
 
Preparation of cellular fractions. 
For the preparation of cellular fractions, we used 4 g of pooled livers of each 
experimental group and animal model and followed the protocol shown in Figure 1 
adapted from [11] and [25]. In a Potter, the frozen liver was homogenized in cooled 40 
ml of 0.25 M sucrose/5 mM Tris HCl, pH 7.4/ 1.0 mM MgCl2 solution, with protease 
and phosphatase inhibitors (Sigma-Aldrich, Saint Louis, MO, USA), at concentrations 
according to manufacturer instructions. Homogenized tissue was filtered through 
sterile gauze, and centrifuged at 280 g for 5 minutes. The pellet was discarded, and the 
supernatant was centrifuged at 1500 g for 10 minutes, resulting in the pellet, which 
contained nuclei and membranes, and a supernatant that was again centrifuged at 
19000 g for 20 minutes. After this centrifugation, the pellet contained mitochondria, 
lysosomes and peroxisomes, and the supernatant was centrifuged at 34000 g for 30 
minutes. The latter centrifugation step resulted in a new pellet named light 
microsomes, and a supernatant that was centrifuged at 124000 g for 30 minutes. The 
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resulting pellet was dubbed heavy microsomes. Both microsomal fractions were 
diluted until 5 ml with 0.25 M sucrose and 0.015 M CsCl. A discontinuous gradient was 
generated by adding 7 ml of 1.3 M sucrose and 0.015 M CsCl, added on top of the 5 ml 
microsomal-containing fraction. The gradient was centrifuged at 237000 g for 120 
minutes, and the resulting pellet contained the rough ER (rER) [25]. The supernatant 
was diluted in an equal volume of 0.25 M sucrose, and centrifuged at 124000 g for 60 
minutes. The pellet obtained contained the smooth ER (sER). Each obtained sample 
was immediately frozen in liquid nitrogen, and stored at -80 ºC until sample 
processing. 
Extraction and solid phase extraction (SPE). 
In this process, all used chemicals were of CG-MS quality. We used a cellular fraction 
aliquot equivalent to 0.1 g of tissue, according to weight of samples and volumes used 
in each step. Samples was transferred to a centrifuge glass tube and homogenized in 1 
ml of PBS, and 200 microliters of 932 µM 5α-cholestane in dichloromethane as internal 
standard for determining the efficiency of the extraction. Samples were extracted with 
1 mL of hexane and vortexed for 5 seconds. Then, tubes were centrifuged at 2200 g for 
10 minutes, and the organic phase was transferred to a clean tube. To improve the 
efficiency, this extraction process was repeated twice. The collected organic phases 
were combined and a further step of purification using SPE was included in order to 
eliminate other lipids and phospholipids and to improve chromatogram background. 
This is critical for samples with low squalene concentrations, so the obtained hexane 
extracts were passed through a SPE cartridge, EFS SiOH (Análisis Vínicos, Tomelloso, 
Spain; 200 mg/3 mL), previously equilibrated with 1.6 mL of hexane. Elution was 
obtained by adding 1.6 mL of hexane at a constant flow of 1.0-1.5 mL/min. Eluted 
samples were dried using a N2 stream in a thermostatic bath at 55 °C. Then, they were 
dissolved with 200 µL of 72 µM squalane solution in dichloromethane. To facilitate 
complete dissolution of tube residue, they were sonicated for 3 minutes. Samples 
were transferred to 150 µL vial insert into a 2 mL vial and were ready for 
chromatographic analysis. 
Gas chromatography-mass spectrometry (GC-MS). 
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CG analyses were carried out in an Agilent 6890 CG with a 7683B Injector and a 5975B 
MS acquisition parameter unit (Agilent Technologies, Santa Clara, CA, USA), using a 
J&W122-5532 column (Agilent) with a nominal length of 30 m and a diameter of 0.25 
mm and a helium flow of 1 mL/min.  Oven temperature was set up to operate from 
280 to 290 ºC in 15 minutes with a ramp from 5 to 13 minutes. Peak identification was 
done by comparison of the retention times of sample peaks with those of individual 
standards (squalane,  squalene and 5α-cholestane with retention times of  9.8, 11.3, 
and 12.2 minutes), and the ion mass patron of each compound, using the m/z of 69.1 
for squalene, 113 for squalane and 217.2 for 5α-cholestane. The used linear calibration 
curve to determinate squalene concentration was comprised between 0 and 500 µM. 
Concentrations of internal standards were 932 and 72 µM for 5α-cholestane and 
squalane, respectively. 
Histological analyses 
A sample of liver from each animal was stored in neutral formaldehyde and embedded 
in paraffin wax. Sections (4 μm) were stained with hematoxylin and eosin and 
observed using a Nikon microscope. A slide scanner Zeiss AsioScan.Z1 (Zeiss, 
Oberkochen, Germany) was used to record all preparations. Hepatic fat content was 
evaluated by quantifying the extent of lipid droplets in each liver section with Adobe 
Photoshop 7.0 and expressed as percentage of total liver section [8].  
Hepatic lipid analyses 
Hepatic lipids were extracted from approximately 10 mg of liver. The tissue was 
homogenized in 1 ml of PBS. The homogenate was twice extracted with 2 mL of 
chloroform: methanol (2:1). The separated organic phases of each animal were 
combined and evaporated under N2 stream. Extracts were dissolved in 100 μL of 
isopropanol to estimate cholesterol and triglyceride concentrations using commercial 
kits from ThermoFisher Scientific (Waltham, MA, USA) [15]. 
Statistical analyses 
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Results are expressed as median and interquartile range. Comparisons were made 
using the Mann-Whitney U test. Correlations between variables were sought using the 
Spearman’s correlation test. All calculations were performed using SPSS version 15.0 
software (SPSS Inc, Chicago, IL, USA).  Significance was set at P≤ 0.05. 
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Results. 
Histological analyses and chemical composition of the rabbit and mouse liver. 
Figure 2A shows hepatic features of livers of control and squalene supplemented 
rabbits. In Figure 2B is displayed the amount of fat expressed as percentage of surface 
which was close to 5%.  No significant differences were observed by the administration 
of squalene. Likewise, no changes were found for hepatic triglyceride (Figure 2C) and 
cholesterol (Figure 2D) contents. However, a significant increase in squalene content in 
those rabbits supplemented with this compound as 0.5% in their diet was observed 
(Figure 2E).  
In Figure 2F two representative micrographs of control and squalene-supplemented 
APOE-KO mice are shown. As reflected the data of Figure 2G, fat extension in the liver 
of these mice represented a higher amount (25%) when compared to rabbits (Figure 
2B), with no significant difference between control and treated mice. In agreement 
with this, hepatic triglycerides (Figure 2H) did not experience any significant change. 
Squalene administration increased significantly the hepatic cholesterol levels (Figure 
2I) and squalene content (Figure 2J). The amount of squalene observed in this model 
was twice the amount present in rabbits receiving the same food content. 
Hepatic subcellular distribution of squalene in function of treatment. 
In figure 3, the main organelles experiencing changes by the administration of 
squalene have been represented. A differential pattern was observed according to the 
model studied. In this regard, treated rabbits accumulated it in the cytosolic, nuclear 
and plasma membrane, and rough endoplasmic reticulum fractions (Figure 3A). 
Interestingly, mice, with a higher degree of basal steatosis as above mentioned, 
showed a preferential increase in lipid droplets, nuclear and plasma membrane, and 
smooth reticulum fractions (Figure 3B).  
Associations among hepatic parameters 
To gain insight into the meaning of observed changes, a correlation analysis was 
carried out among different parameters. As shown in Figure 4 A and C, squalene 
content was directly associated with hepatic cholesterol content in both studied 
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models. Equally associated was found the content of triglycerides and fat assayed by 
the morphometric procedure in mice (Figure 4 B). 
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Discussion. 
 
The present work has characterized in depth the distribution of squalene in subcellular 
fractions thanks to an optimization of its assay and using the combined analytical 
power of gas chromatography and mass spectrometry. Both animal models 
accumulated squalene in the liver being more sensitive the mouse model. Equally, 
there was a differential distribution in both models in terms of preferential distribution 
in endoplasmic reticulum and cytosolic compartments. 
Our data using two animal models show clearly that exogenous administration of 
squalene in vivo increases the reservoir in the liver independently of studied model in 
agreement with classical studies [13]. Besides, the differences in accumulation may be 
due to experimental settings such as dietary fat percentage in used diets or the 
models. When we administered squalene in low fat diet to APOE-KO mice, we 
observed low levels of hepatic squalene [8]. Based on the latter data, it seems 
plausible that dietary fat content is crucial to facilitate intestinal squalene absorption. 
Nevertheless, it cannot be rejected the potential role of hepatic adaptation to engorge 
more squalene when large lipid droplets are present, such is the case of a more severe 
steatotic liver developed by APOE-KO mice fed Western diet.  
The present experiments were designed to reduce the dose of (1 g/kg) squalene 
previously used [8] in an attempt to reach the moderate dietary intakes reported 
using virgin olive [21]. It was selected the 0.5 mg/kg because the 0.25 mg/kg dose 
was not particularly effective in many plasma parameters [5]. However, squalene 
administration failed to decrease hepatic triglyceride content at the 0.5 mg/kg dose, 
suggesting that squalene dose seems to be critical regarding this effect. 
The distribution of squalene among cytosolic and reticulum in both models is 
confirmatory for the liver of results observed by Tilvis et al [27] in adipocytes. 
However, a profound analytical development has unveiled a new source (nuclei and 
plasma membranes) with important consequences regarding transcriptional changes 
induced by squalene action [19,20]. This nuclear location could also be the responsible 
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for the protection of DNA damage reported in MCF10A human mammary epithelial 
cells [30]. Equally remarkable is the differential accumulation in potential small vesicles 
isolated from cytosol for rabbits or the large lipid droplet isolated at lower centrifugal 
force for mice. This fact may be related to the higher amount of squalene in the latter 
model and it would have required an expansion of lipid droplets in terms of 
phospholipids and proteins [26]. In yeast, it has been proposed that squalene is 
lipotoxic if not adequately sequestered in lipid droplets [29]. Surprisingly,  it seems 
that the liver can handle it with ease due to the low toxicity observed in sharks, which 
accumulate [21]. 
New unsuspected information gained through meticulous analyses of reticulum adds a 
complexity that could be species-specific. No much is known for proteins carrying 
squalene in the aqueous cell environment. In this regard, supernatant protein factor 
has been proposed as a candidate [2] but how its mechanism of action is not well 
known. Selective accumulation of squalene in specific domains of reticulum and the 
positive association with cholesterol content observed in our models (Figure 4) are 
suggestive of different location of squalene epoxidase, the enzyme using squalene as 
substrate. Besides, considering the ability of this compound to be intercalated into the 
layer of membranes [9] is may just merely represent the existence of these specific 
domains able to accrue it. 
In conclusion, the present results provide a suggestive framework to further advance 
in the knowledge of protective action of squalene in the liver by opening unsuspected 
locations of squalene in nuclei and the cellular dynamics of squalene between 
vesicles/lipid droplets and endoplasmic reticulum. These facts warrant further 
research to unveil them. 
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Figure 1. Flow chart displaying steps required to isolate different subcellular 
fractions. 
 
Figure 2. Histological analyses and chemical composition of the liver. A and F, 
Representative micrographs, bar denotes 20 µm; B and G, hepatic fat 
expressed as percentage of surface; C and H, hepatic triglycerides mg/ g; D 
and I, hepatic cholesterol mg/ g and  E and J, μg of squalene/ g. Results are 
shown as median and interquartile ranges of n=6 for each rabbit group, 
and n=10 and n=9 for mouse control and squalene groups. Statistical 
analysis was carried out by Mann-Whitney U –test. *, P<0.05 and **, 
P<0.01. 
 
Figure 3.  Subcellular distribution of squalene in function of treatment. A, rabbit 
and B, mouse. Results are shown as average of three analytical 
determinations of the pooled samples of n=6 for each rabbit group, and 
n=10 and n=9 for mouse control and squalene groups. 
 
Figure 4.  Significant associations among hepatic parameters. A, relationship 
between squalene and cholesterol contents in rabbits. B, relationship 
between triglyceride and morphometric analysis of lipid content in mice. C, 
relationship between squalene and cholesterol contents in mice. 
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